Report Detail
Global Cystic Fibrosis (CF) Therapeutics Market Professional Survey Report 2019
- RnM3759964 |
- 18 September, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Cystic fibrosis is a genetic disease that causes continuous lung infections and breathing problem over time. It is a progressive disease. The presence of imperfect gene causes a thick, sticky buildup of mucus in the lungs, intestine liver, pancreas, and other organs. The mucus in the lungs clogs airways and traps bacteria leading to infections that causes savior lung damage, and respiratory failure. The mucus prevents in the pancreas discharge the digestive enzymes that allow the body to break down food and absorb vital nutrients. This disease is caused by mutation in gene, cystic fibrosis trans membrane conductance regulator (CFTR) is a membrane protein in vertebrates, a protein required for regulating sweat, mucus and body secretions.
The global Cystic Fibrosis (CF) Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cystic Fibrosis (CF) Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cystic Fibrosis (CF) Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cystic Fibrosis (CF) Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cystic Fibrosis (CF) Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Vertex Pharmaceuticalsorporated
Gilead
AbbVie,
Novartis AG
F. Hoffmann-La Roche Ltd
Alaxia
Merck & Co.
AIT (Advanced Inhalation Therapies)
ALLERGAN
AstraZeneca
Teva Pharmaceutical Industries Ltd
Alcresta
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Pancreatic enzyme supplements
Mucolytics
Bronchodilators
CFTR modulators
Segment by Application
Oral drugs
Inhaled drugs
Table of Contents
Executive Summary
1 Industry Overview of Cystic Fibrosis (CF) Therapeutics
- 1.1 Definition of Cystic Fibrosis (CF) Therapeutics
- 1.2 Cystic Fibrosis (CF) Therapeutics Segment by Type
- 1.2.1 Global Cystic Fibrosis (CF) Therapeutics Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Pancreatic enzyme supplements
- 1.2.3 Mucolytics
- 1.2.4 Bronchodilators
- 1.2.5 CFTR modulators
- 1.3 Cystic Fibrosis (CF) Therapeutics Segment by Applications
- 1.3.1 Global Cystic Fibrosis (CF) Therapeutics Consumption Comparison by Applications (2014-2025)
- 1.3.2 Oral drugs
- 1.3.3 Inhaled drugs
- 1.4 Global Cystic Fibrosis (CF) Therapeutics Overall Market
- 1.4.1 Global Cystic Fibrosis (CF) Therapeutics Revenue (2014-2025)
- 1.4.2 Global Cystic Fibrosis (CF) Therapeutics Production (2014-2025)
- 1.4.3 North America Cystic Fibrosis (CF) Therapeutics Status and Prospect (2014-2025)
- 1.4.4 Europe Cystic Fibrosis (CF) Therapeutics Status and Prospect (2014-2025)
- 1.4.5 China Cystic Fibrosis (CF) Therapeutics Status and Prospect (2014-2025)
- 1.4.6 Japan Cystic Fibrosis (CF) Therapeutics Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Cystic Fibrosis (CF) Therapeutics Status and Prospect (2014-2025)
- 1.4.8 India Cystic Fibrosis (CF) Therapeutics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Cystic Fibrosis (CF) Therapeutics
- 2.3 Manufacturing Process Analysis of Cystic Fibrosis (CF) Therapeutics
- 2.4 Industry Chain Structure of Cystic Fibrosis (CF) Therapeutics
3 Development and Manufacturing Plants Analysis of Cystic Fibrosis (CF) Therapeutics
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Cystic Fibrosis (CF) Therapeutics Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Cystic Fibrosis (CF) Therapeutics
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Cystic Fibrosis (CF) Therapeutics Production and Capacity Analysis
- 4.2 Cystic Fibrosis (CF) Therapeutics Revenue Analysis
- 4.3 Cystic Fibrosis (CF) Therapeutics Price Analysis
- 4.4 Market Concentration Degree
5 Cystic Fibrosis (CF) Therapeutics Regional Market Analysis
- 5.1 Cystic Fibrosis (CF) Therapeutics Production by Regions
- 5.1.1 Global Cystic Fibrosis (CF) Therapeutics Production by Regions
- 5.1.2 Global Cystic Fibrosis (CF) Therapeutics Revenue by Regions
- 5.2 Cystic Fibrosis (CF) Therapeutics Consumption by Regions
- 5.3 North America Cystic Fibrosis (CF) Therapeutics Market Analysis
- 5.3.1 North America Cystic Fibrosis (CF) Therapeutics Production
- 5.3.2 North America Cystic Fibrosis (CF) Therapeutics Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Cystic Fibrosis (CF) Therapeutics Import and Export
- 5.4 Europe Cystic Fibrosis (CF) Therapeutics Market Analysis
- 5.4.1 Europe Cystic Fibrosis (CF) Therapeutics Production
- 5.4.2 Europe Cystic Fibrosis (CF) Therapeutics Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Cystic Fibrosis (CF) Therapeutics Import and Export
- 5.5 China Cystic Fibrosis (CF) Therapeutics Market Analysis
- 5.5.1 China Cystic Fibrosis (CF) Therapeutics Production
- 5.5.2 China Cystic Fibrosis (CF) Therapeutics Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Cystic Fibrosis (CF) Therapeutics Import and Export
- 5.6 Japan Cystic Fibrosis (CF) Therapeutics Market Analysis
- 5.6.1 Japan Cystic Fibrosis (CF) Therapeutics Production
- 5.6.2 Japan Cystic Fibrosis (CF) Therapeutics Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Cystic Fibrosis (CF) Therapeutics Import and Export
- 5.7 Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Analysis
- 5.7.1 Southeast Asia Cystic Fibrosis (CF) Therapeutics Production
- 5.7.2 Southeast Asia Cystic Fibrosis (CF) Therapeutics Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Cystic Fibrosis (CF) Therapeutics Import and Export
- 5.8 India Cystic Fibrosis (CF) Therapeutics Market Analysis
- 5.8.1 India Cystic Fibrosis (CF) Therapeutics Production
- 5.8.2 India Cystic Fibrosis (CF) Therapeutics Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Cystic Fibrosis (CF) Therapeutics Import and Export
6 Cystic Fibrosis (CF) Therapeutics Segment Market Analysis (by Type)
- 6.1 Global Cystic Fibrosis (CF) Therapeutics Production by Type
- 6.2 Global Cystic Fibrosis (CF) Therapeutics Revenue by Type
- 6.3 Cystic Fibrosis (CF) Therapeutics Price by Type
7 Cystic Fibrosis (CF) Therapeutics Segment Market Analysis (by Application)
- 7.1 Global Cystic Fibrosis (CF) Therapeutics Consumption by Application
- 7.2 Global Cystic Fibrosis (CF) Therapeutics Consumption Market Share by Application (2014-2019)
8 Cystic Fibrosis (CF) Therapeutics Major Manufacturers Analysis
- 8.1 Vertex Pharmaceuticalsorporated
- 8.1.1 Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Production Sites and Area Served
- 8.1.2 Vertex Pharmaceuticalsorporated Product Introduction, Application and Specification
- 8.1.3 Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Gilead
- 8.2.1 Gilead Cystic Fibrosis (CF) Therapeutics Production Sites and Area Served
- 8.2.2 Gilead Product Introduction, Application and Specification
- 8.2.3 Gilead Cystic Fibrosis (CF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 AbbVie,
- 8.3.1 AbbVie, Cystic Fibrosis (CF) Therapeutics Production Sites and Area Served
- 8.3.2 AbbVie, Product Introduction, Application and Specification
- 8.3.3 AbbVie, Cystic Fibrosis (CF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Novartis AG
- 8.4.1 Novartis AG Cystic Fibrosis (CF) Therapeutics Production Sites and Area Served
- 8.4.2 Novartis AG Product Introduction, Application and Specification
- 8.4.3 Novartis AG Cystic Fibrosis (CF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 F. Hoffmann-La Roche Ltd
- 8.5.1 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Production Sites and Area Served
- 8.5.2 F. Hoffmann-La Roche Ltd Product Introduction, Application and Specification
- 8.5.3 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Alaxia
- 8.6.1 Alaxia Cystic Fibrosis (CF) Therapeutics Production Sites and Area Served
- 8.6.2 Alaxia Product Introduction, Application and Specification
- 8.6.3 Alaxia Cystic Fibrosis (CF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Merck & Co.
- 8.7.1 Merck & Co. Cystic Fibrosis (CF) Therapeutics Production Sites and Area Served
- 8.7.2 Merck & Co. Product Introduction, Application and Specification
- 8.7.3 Merck & Co. Cystic Fibrosis (CF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 AIT (Advanced Inhalation Therapies)
- 8.8.1 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Production Sites and Area Served
- 8.8.2 AIT (Advanced Inhalation Therapies) Product Introduction, Application and Specification
- 8.8.3 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 ALLERGAN
- 8.9.1 ALLERGAN Cystic Fibrosis (CF) Therapeutics Production Sites and Area Served
- 8.9.2 ALLERGAN Product Introduction, Application and Specification
- 8.9.3 ALLERGAN Cystic Fibrosis (CF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 AstraZeneca
- 8.10.1 AstraZeneca Cystic Fibrosis (CF) Therapeutics Production Sites and Area Served
- 8.10.2 AstraZeneca Product Introduction, Application and Specification
- 8.10.3 AstraZeneca Cystic Fibrosis (CF) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Teva Pharmaceutical Industries Ltd
- 8.12 Alcresta
9 Development Trend of Analysis of Cystic Fibrosis (CF) Therapeutics Market
- 9.1 Global Cystic Fibrosis (CF) Therapeutics Market Trend Analysis
- 9.1.1 Global Cystic Fibrosis (CF) Therapeutics Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Cystic Fibrosis (CF) Therapeutics Regional Market Trend
- 9.2.1 North America Cystic Fibrosis (CF) Therapeutics Forecast 2019-2025
- 9.2.2 Europe Cystic Fibrosis (CF) Therapeutics Forecast 2019-2025
- 9.2.3 China Cystic Fibrosis (CF) Therapeutics Forecast 2019-2025
- 9.2.4 Japan Cystic Fibrosis (CF) Therapeutics Forecast 2019-2025
- 9.2.5 Southeast Asia Cystic Fibrosis (CF) Therapeutics Forecast 2019-2025
- 9.2.6 India Cystic Fibrosis (CF) Therapeutics Forecast 2019-2025
- 9.3 Cystic Fibrosis (CF) Therapeutics Market Trend (Product Type)
- 9.4 Cystic Fibrosis (CF) Therapeutics Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Cystic Fibrosis (CF) Therapeutics Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Cystic Fibrosis (CF) Therapeutics . Industry analysis & Market Report on Cystic Fibrosis (CF) Therapeutics is a syndicated market report, published as Global Cystic Fibrosis (CF) Therapeutics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Cystic Fibrosis (CF) Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
